CD36 and chronic myelogenous leukemia, BCR-ABL1 positive: Patients with chronic myelogenous leukemia (CML) and high expression of CD36 often have worse prognoses [89], higher levels of FAO in the leukemia stem cell subgroup of CML, and resistance to AraC, but the specific relationship between FAO and drug resistance and its mechanism is still unclear [90].